The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19
Authors:
- 26 October 2021
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 48 (01) , 019-030
Abstract
The cardinal pathology of coronavirus disease 2019 (COVID-19) is a primary infection of pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local inflammatory response, often accompanied by cytokine storm and acute respiratory distress syndrome, especially in patients with severe disease. Systemic propagation of the disease may associate with thrombotic events, including deep vein thrombosis, pulmonary embolism, and thrombotic microangiopathy, which are important causes of morbidity and mortality in patients with COVID-19. This narrative review describes current knowledge of the pathophysiological mechanisms of COVID-19-associated coagulopathy, with focus on prothrombotic changes in hemostatic mediators, including plasma levels of clotting factors, natural anticoagulants, components of fibrinolytic system, and platelets. It will also highlight the central role of endothelial cells in COVID-19-associated coagulopathy. This narrative review discusses also potential therapeutic strategies for managing thrombotic complications. Awareness by medical experts of contributors to the pathogenesis of thrombotic events in COVID-19 is imperative to develop therapeutics not limited to regular anticoagulants. Instituting cooperation among medical personnel and researchers may lessen this novel virus' impact now, and in the event of recurrence. Publication Date: 25 October 2021 (online) © 2021. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAKeywords
This publication has 151 references indexed in Scilit:
- Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging techniqueHaematologica, 2012
- Endothelial Cell Processing and Alternatively Spliced Transcripts of Factor VIII: Potential Implications for Coagulation Cascades and Pulmonary HypertensionPLOS ONE, 2010
- Role of adipose tissue in haemostasis, coagulation and fibrinolysisObesity Reviews, 2009
- The coagulation system and pulmonary endothelial function in acute lung injuryMicrovascular Research, 2009
- FVIII production by human lung microvascular endothelial cellsBlood, 2006
- Tissue Factor in Infection and Severe InflammationSeminars in Thrombosis and Hemostasis, 2006
- A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)Pathology, 2003
- Interaction Between Interleukin-6 and the Natural Anticoagulant System in Acute StrokeJournal of Interferon & Cytokine Research, 2000
- Interaction between Protein S and Complement C4b-binding Protein (C4BP)Journal of Biological Chemistry, 1999
- The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant functionBritish Journal of Haematology, 1990